10 Magnificent Stocks That Can Make You Richer in 2025

A new year brings with it new opportunities to grow your wealth on Wall Street.

For a second straight year, investors have been given every reason to smile. As of this writing, with one trading day left in 2024, the iconic Dow Jones Industrial Average, benchmark S&P 500, and growth stock-powered Nasdaq Composite have respectively gained 13%, 24%, and 30%!

Regardless of whether the bulls remain in firm control or the feisty bear returns to Wall Street, bargains can still be found in the new year for opportunistic investors.

What follows are 10 magnificent stocks that can make you richer in 2025.

Image source: Getty Images.

1. Meta Platforms

The first sensational stock that can pad investment portfolios in 2025 is social media titan Meta Platforms (META 0.83%), which remains relatively inexpensive given annual sales growth of around 20%.

Though most investors are focused on Meta’s artificial intelligence (AI) and metaverse ambitions, they continue to underestimate its social media dominance. While advertising isn’t the game changer AI is, it’s important to recognize that no social media company comes close to attracting the 3.29 billion daily active users Meta did from its family of apps during the third quarter. Businesses will pay a premium to get their message in front of users, which bodes positively for the company’s growth prospects.

Meta is sitting on a treasure chest of capital, as well. It closed out September with $70.9 billion in cash, cash equivalents, and marketable securities, and looks to be on track to have generated north of $85 billion in operating cash flow in 2024. This cash affords Meta the opportunity to aggressively invest in high-growth initiatives (AI and the metaverse), which can set the company up for even faster growth in the latter-half of the decade.

2. Pfizer

Perhaps no company has a greater chance to bounce back stronger in 2025 than pharmaceutical stock Pfizer (PFE -0.07%). Although shares of the company have been pressured by a decline in sales for COVID-19 therapies Comirnaty and Paxlovid, Pfizer’s novel-drug portfolio is in better shape now than it was four years ago.

Excluding Pfizer’s COVID-19 therapies, Pfizer’s sales jumped by 14% during the September-ended quarter, with double-digit sales growth from its oncology and specialty care segments. Inclusive of Comirnaty and Paxlovid, Pfizer’s sales are forecast to have grown by 49% (around $20.6 billion) between 2020 and 2024.

Furthermore, Pfizer’s $43 billion acquisition of Seagen, which closed in December 2023, paves the way for an expansive cancer-drug pipeline and substantial cost savings that should result in meaningful earnings per share (EPS) accretion beginning this year.

Pfizer’s forward price-to-earnings (P/E) ratio of 9 and 6.5% yield scream “bargain!”

NEE Total Return Level Chart

NextEra Energy has delivered a positive total return for investors in 20 of the last 23 years. NEE Total Return Level data by YCharts.

3. NextEra Energy

America’s largest electric utility by market cap, NextEra Energy (NEE 0.83%) is another stock that can make investors richer in the new year. NextEra has delivered a positive total return, including dividends, to its shareholders in 20 of the last 23 years.

One thing investors get with NextEra Energy is cash flow transparency and predictability. No matter how well or poorly the U.S. economy is performing, the energy needs of American households don’t change much from one year to the next. Since most electric utilities operate as monopolies or duopolies in the areas they service, it leads to consistent cash flow.

NextEra Energy is also a clear leader in renewable energy. No company in the world generates more capacity from solar or wind power than NextEra. Though investing in green-energy solutions hasn’t been cheap, it’s notably reduced the company’s electricity-generation costs. The end result is high-single-digit annual EPS growth and targeted double-digit annual growth in its dividend.

O Dividend Chart

Realty Income pays a monthly dividend and has increased its payout for 109 consecutive quarters. O Dividend data by YCharts.

4. Realty Income

Wall Street’s premier retail real estate investment trust (REIT) and monthly (yes, monthly!) dividend payer Realty Income (O 0.59%) can make investors richer in 2025, as well. Though REITs have been weighed down by higher Treasury yields — income seekers may opt for the safety of government bonds when yields are comparable to REITs — a Federal Reserve rate-easing cycle can open the door for REITs to thrive, once more.

Realty Income’s not-so-subtle secret to success is that it leases to predominantly well-known, time-tested, stand-alone businesses that lure foot traffic in any economic climate. Examples include grocery stores, convenience stores, dollar stores, drug stores, and automotive service locations, which provide basic need goods and services. This leads to predictable funds from operations for Realty Income.

This is also a company that’s expanding its reach beyond retail. It formed a joint venture with Digital Realty Trust for build-to-suit data centers, entered into two leasing deals in the gaming industry, and acquired Spirit Realty Capital in January 2024 to complement its commercial real estate assets and diversify into new verticals.

Realty Income is valued at less than 12 times forecast cash flow in 2025, which represents a 29% discount to its average multiple to cash flow over the trailing-five-year period.

A person using a tablet to peruse a pinned board on Pinterest.

Image source: Pinterest.

5. Pinterest

Another social media stock that looks to be a no-brainer buy in 2025 is Pinterest (PINS 2.58%). Even though Wall Street was less-than-thrilled with the company’s fourth-quarter sales guidance, Pinterest’s key performance indicators continue to move in the right direction.

As of the end of September, Pinterest had 537 million monthly active users. While this doesn’t rival Meta’s 3.29 billion daily active users, it does afford Pinterest improved ad-pricing power over time. Pinterest’s average revenue per user (ARPU) has continued to grow globally, with double-digit ARPU increases in emerging markets.

Additionally, Pinterest’s operating model is well-insulated from the changes app developers have made that allow users to block data-tracking tools. Whereas most social media platforms rely heavily on data-tracking tools to help advertisers target users, Pinterest’s entire platform is built on its users willingly and freely sharing the things, places, and services that interest them.

A forward P/E of 16 and a price-to-earnings-growth ratio (PEG ratio) of well below 1 make Pinterest a phenomenal value.

6. SentinelOne

Cybersecurity up-and-comer SentinelOne (S -0.28%) is the sixth magnificent stock that can make investors richer this year.

The great thing about cybersecurity solutions is they’ve evolved into a basic necessity service. With businesses shifting their data and that of their customers online and into the cloud at an accelerated pace, third-party providers like SentinelOne are increasingly being relied upon to protect this data.

To build on the above, SentinelOne is a subscription-driven model, which means consistent cash flow quarter after quarter. More importantly, subscriptions tend to keep existing clients loyal to its suite of AI- and machine learning-powered software-as-a-service solutions. This annual recurring revenue grew by 29% in the company’s latest quarter.

With subscriptions lifting its adjusted gross margin to 80%, investors should expect SentinelOne’s losses to shrink in the new year.

A small pyramid of cardboard boxes and a mini orange handbasket set atop a tablet and open laptop.

Image source: Getty Images.

7. Alibaba Group

Despite the concerns investors have about China stocks with Donald Trump readying to take office for his nonconsecutive second term, leading e-commerce company Alibaba Group (BABA 0.21%) is ripe for the picking.

Although e-commerce sales have long since matured in the U.S., they’re still a sizable growth opportunity in the world’s No. 2 economy, thanks in part to its burgeoning middle class. Alibaba’s Taobao and Tmall combined to account for around half of all online retail sales market share in 2023, according to the International Trade Administration.

What’s more, Alibaba Cloud is currently the No. 1 provider of cloud infrastructure services in China. Cloud services offer substantially juicier margins than online retail sales, which should lead to margin and profit expansion for Alibaba throughout the decade.

The icing on the cake is that Alibaba has over $33 billion in net cash on its balance sheet, which allows it to buy back its own shares and makes its microscopic forward P/E of 9 look even more attractive.

8. BioMarin Pharmaceutical

Specialty biotech BioMarin Pharmaceutical (BMRN 0.31%) is another phenomenal company that can help fatten up investor’s portfolios in 2025. Even though new competitors may be entering the arena to treat achondroplasia, which would be bad news for BioMarin’s fast-growing drug Voxzogo, there are still plenty of catalysts to be excited about.

For starters, Voxzogo may hold a competitive advantage with regard to label expansion opportunities. Being able to treat younger achondroplasia patients should lift Voxzogo’s sales and give the drug an opportunity to eventually peak above $1 billion in annual revenue. As a reminder, BioMarin’s orphan drug focus gives the company exceptional pricing power.

Secondly, BioMarin’s pipeline remains promising. The company’s September Investor Day meeting forecast two new drug launches by 2027 and a total of 11 by 2034. Perhaps most important, BioMarin has narrowed its pipeline down to its most-promising candidates and expects total sales to reach $4 billion by 2027, which represents expected sales growth of 42% over the next three years.

With BioMarin’s EPS projected to top $5 per share by 2027, the time to buy is now.

A person in a wheelchair holding a coffee mug while looking at an open laptop in their home.

Image source: Getty Images.

9. Fiverr International

For those of you looking for something a bit more off the radar, online-services marketplace Fiverr International (FVRR 1.10%) has all the necessary tools to make investors richer in the new year.

Since the COVID-19 pandemic, we’ve witnessed a discernable shift in how Americans work. While some have returned to the office, more are working remotely than when this decade began. This plays in perfectly to Fiverr’s platform, which is designed to connect freelancers with buyers through its marketplace.

Price transparency is one reason Fiverr stands out from other freelancer marketplaces. Whereas most freelancers price their services by the hour on other platforms, they do so as a completed service on Fiverr. This cost transparency is likely a big reason why spend per buyer keeps climbing for Fiverr.

Further, Fiverr is netting a take rate of 33.9% — this is the percentage of each deal negotiated on its platform, including fees, it gets to keep. Fiverr’s take rate is nearly double that of its rivals and should lead to superior margins.

V Total Return Level Chart

Visa has delivered steady returns for its shareholders since going public in March 2008. V Total Return Level data by YCharts.

10. Visa

The 10th magnificent stock that can make you richer in 2025 is none other than payment-processing goliath Visa (V -0.46%). While financial stocks are highly cyclical, Visa has shown that its competitive advantages allow it to outperform in virtually any economic climate.

One of Visa’s keys to success is that it strictly sticks to payment facilitation. Even though some of its peers also lend, its management team has avoided such temptations. The advantage of this approach is that when recessions do occur, Visa doesn’t have to set aside capital to cover loan losses or credit delinquencies.

Investors shouldn’t overlook Visa’s mouthwatering international opportunity, either. Sustained double-digit growth in cross-border payment volume is indicative of emerging markets still being predominantly underbanked. Visa has the operating cash flow necessary to organically or acquisitively enter new markets in order to take advantage of this outsized growth potential.

Source link

Visited 1 times, 1 visit(s) today

Related Article

Prediction: Nvidia Will Beat the Market. Here’s Why.

Beating the market isn’t a new feat for Nvidia (NVDA 3.20%). The artificial intelligence (AI) chip giant did this over the past two years, soaring more than 170% in 2024 and 238% in 2023 — that’s compared to double-digit gains for the S&P 500 in each of these years. Why such an explosive performance? Nvidia

Will C3.ai Be the Palantir of 2025?

Palantir was the top-performing stock in the S&P 500 last year, but a smaller competitor is emerging on the scene. When it comes to artificial intelligence (AI), odds are you think about “Magnificent Seven” stocks such as Microsoft, Nvidia, or Tesla simply by default. But in 2024, one smaller player emerged from the deepest corners

Minnesota’s Walter Mondale left behind a eulogy for Jimmy Carter

MINNEAPOLIS — There will be a special eulogy Thursday at the state funeral for the late President Jimmy Carter. Carter’s vice president, Walter Mondale, died in 2021 but he left behind a eulogy that his son Ted will read at the service.  In 2015, Carter, who was 92 years old at the time, announced he

China scrambles to shore up sliding yuan and stock markets By Reuters

By Samuel Shen and Ankur Banerjee SHANGHAI/SINGAPORE (Reuters) – China’s stock exchanges and central bank scurried to defend a tumbling yuan and falling stock markets on Monday, trying to soothe investors concerned about Donald Trump’s return to the White House and Beijing’s ability to revive the economy. With two weeks before Trump begins a second

China’s regulators rush to reassure investors as equities and renminbi fall

Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. China’s regulators sought to reassure markets on Monday as equities and the renminbi extended losses in a rocky start to the year, following weak economic data and geopolitical uncertainty ahead of Donald Trump’s inauguration. Mainland

Prime Minister Justin Trudeau expected to announce resignation: report

Prime Minister Justin Trudeau is reportedly expected to resign from his position as early as Monday, according to Canadian media. The news was first reported by the Globe and Mail on Sunday night, citing three sources. The outlet said that it is unclear when exactly the Liberal Party leader will step down, but a resignation

Shanghai and Shenzhen stock exchanges woo foreign investors after worst start since 2016

China’s top two stock exchanges met representatives of foreign money managers and investment banks, as regulators look at ways to shore up sentiment among overseas investors after the market’s worst start to a year since 2016. The shift to a more aggressive monetary and fiscal easing at last month’s Politburo meeting and subsequent economic work

恒指半日跌53點 科指跌0.01% 低於10天線 農夫山泉、東方甄選跌3% (12:06) – 20250106 – 即時財經新聞

恒指今早高開88點,高位升91點,低位跌112點,高低波幅204點。上升股份比例為22.12%,下跌為31%,無升跌為46.87%。 恒指半日跌53點或0.27%,報19706點,大市成交金額707億元;國指跌10點或0.14%,報7149點。恒生科技指數收報4402點,跌0.01%。 藍籌股成交金額286.68億元,佔大市成交40.54%;科指成份股成交金額181.4億元,佔大市成交25.65%;國指成份股成交金額259.92億元,佔大市成交36.76%。 24隻雙櫃台股,總成交0.21億元人民幣,相當於約0.22億港元,佔大市成交的0.03%。 窩輪及牛熊證成交金額減少4.29%,至92.77億元,佔大市成交13.12%。牛熊證成交金額49.43億元,增加0.06%;窩輪成交金額43.33億元,減少8.83%。 藍籌36隻升,41隻下跌,6隻無升跌。信義光能(0968)升5.02%,收報3.14元,是升幅最大的藍籌,農夫山泉(9633)跌3.42%,收報32.5元,是跌幅最大的藍籌。 恒生科技指數成份股15隻升,15隻下跌。升幅最大的是蔚來(9866)收報37元,升5.26%;跌幅最大的是東方甄選(1797)收報16.18元,跌3.58%。 恒指續低於10天線(19873.67點)。科指續低於10天線(4451.99點)。 北水南下合計淨流入33.12億元,較上日減少64.27%,連續第12日流入,累計流入755.3億元,對上一次連續12日淨流入是11月29日。北水本月累計流入190.92億元,按月減少80%。 龍光(3380):與若干境外債權人就境外債整體重組條款達成一致。收報1元,跌1.96%。 優必選(9880)曾反彈12% 再有董事承諾一年禁售持股。收報52元,升12.31%。 泛遠國際(2516)63萬美元購美國清關服務供應商30%權益。收報0.85元,升10.39%。 吉利汽車(0175)據報年內將推出「超醇電混」新車。收報14.3元,升0.85%。 萬科企業(2202)去年銷售額大減1301億人幣。收報5.01元,跌1.57%。 盈健醫療(1419)以3885萬元收購祐德牙醫診所75%股權。收報0.79元,無升跌。 聯華超市(0980)1億人幣租上海物業開超市。收報0.365元,無升跌。 萬物雲(2602)斥2.3億人幣全購購物業管理商中洲物業。收報20.1元,升0.6%。 非凡領越(0933)私有化堡獅龍今發股東通函,獨立財顧認為公平合理籲支持。收報0.57元,無升跌。 卓越教育(3978)未來3年派息比率擬由50%升至70%。創52周高,見4.24元,收報4.08元,升8.51%。 澳門郵電局:數碼通(0315)澳門客戶已全過渡至澳門電訊。收報4.09元,跌0.49%。 廣汽集團(2238)上月銷量升9%,去年銷量200萬輛跌20%。收報3.11元,跌1.27%。 信利國際(0732)終止分拆業務到內地上市。收報1.15元,升0.88%。 鄭家純增持周大福珠寶(1929)10萬股,新世界股價今年首跌破5元大關。收報6.58元,跌0.45%。 世茂服務(0875)8316萬人幣購世路源環境33%股權,成全資附屬。收報1.31元,跌6.43%。 平安資管增持工行(1398)。收報4.91元,升0.41%。 包浩斯(0483)首3財季同店銷售按年增長2%,上季增長10%。收報0.235元,無升跌。 破頂股表現 破頂股包括,瑞誠中國傳媒(1640)創上市新高,見3.7元,收報3.63元,升8.04%;達力普控股(1921)創上市新高,見9.48元,收報9.48元,升4.64%;康耐特光學(2276)創上市新高,見27.2元,收報26.8元,升7.63%;經緯天地(2477)創上市新高,見6.69元,收報6.42元,升0.16%;小米集團-WR(81810)創上市新高,見35元,收報34.6元,升1.76%;健康之路(2587)創上市新高,見14.7元,收報14.5元,升12.93%;A南方港元(3053)創上市新高,見1143.5元,收報1142.9元,跌0.04%;AGX美元(3137)創上市新高,見1052.55元,收報1052.55元,升0.31%;A博時港元(3152)創上市新高,見1082.7元,收報1082.35元,跌0.03%;恒生標普五百(3195)創上市新高,見10元,收報9.295元,升0.81%;A博時美元(3196)創上市新高,見8415.3元,收報8415.3元,升0.22%;湯臣集團(0258)創52周高,見3.28元,收報3.06元,跌3.47%;紛美包裝(0468)創52周高,見2.6元,收報2.58元,無升跌;中視金橋(0623)創52周高,見1.61元,收報1.58元,升5.33%;東吳水泥(0695)創52周高,見2.9元,收報2.7元,跌4.59%;位元堂(0897)創52周高,見0.315元,收報0.31元,升24%;國際資源(1051)創52周高,見3.15元,收報3.06元,升1.32%;檳傑科達(1665)創52周高,見0.95元,收報0.94元,無升跌;港亞控股(1723)創52周高,見0.46元,收報0.46元,升3.37%;依波路(1856)創52周高,見2.03元,收報1.8元,升0.56%;和鉑醫藥-B(2142)創52周高,見2.44元,收報2.44元,升17.31%。 破頂指數成份股包括,小米(1810)創上市新高,見36.85元,收報36.55元,升0.83%。 破底股方面 29隻股份創上市新低,其中十隻包括,百威(1876)低見7.03元,收報7.08元,跌1.94%;晨鳴紙業(1812)低見1.18元,收報1.18元,跌1.67%;新世界發展(0017)低見4.91元,收報5元,升1.01%;COSMOPOL INT’L(0120)低見0.12元,收報0.123元,跌6.82%;第七大道(0797)低見0.83元,收報0.83元,跌25.23%;麗豐控股(1125)低見1.05元,收報1.05元,跌4.55%;歐康維視生物-B(1477)低見4.09元,收報4.17元,跌3.7%;力高集團(1622)低見0.187元,收報0.188元,跌6.47%;百威亞太(1876)低見7.03元,收報7.08元,跌1.94%;鳳凰衛視(2008)低見1.3元,收報1.3元,跌3.7%。 35隻股份創52周低,其中十隻包括,大快活集團(0052)低見5.98元,收報5.99元,跌0.33%;綠景中國地產(0095)低見0.38元,收報0.385元,無升跌;和記電訊香港(0215)低見0.91元,收報0.92元,無升跌;信德集團(0242)低見0.61元,收報0.62元,跌1.59%;陸氏集團(越南)(0366)低見0.7元,收報0.72元,跌2.7%;香港興業國際(0480)低見0.83元,收報0.85元,跌1.16%;金源發展國際實業(0677)低見0.375元,收報0.375元,跌1.32%;長盈集團(控股)(0689)低見0.017元,收報0.02元,跌4.76%;華聯國際(0969)低見0.08元,收報0.08元,跌6.98%;恒安國際(1044)低見21.4元,收報21.5元,跌1.6%。 異動股 上升異動股,包括,融科控股(2323)收報0.026元,升30%;傲迪瑪汽車(8418)收報0.445元,升25.35%;位元堂(0897)創52周高,見0.315元,收報0.31元,升24%;中國健康科技集團(1069)收報0.043元,升22.86%;和鉑醫藥-B(2142)創52周高,見2.44元,收報2.44元,升17.31%;新石文化(1740)收報0.093元,升16.25%;新明中國(2699)收報0.015元,升15.38%;百信國際(0574)收報0.054元,升14.89%;瑞強集團(8427)創52周高,見27元,收報26.3元,升14.6%;中國水業集團(1129)收報0.4元,升14.29%;維信金科(2003)收報2.23元,升13.78%。 下跌異動股,包括,第七大道(0797)創上市新低,見0.83元,收報0.83元,跌25.23%;吉盛集團控股(8133)收報0.315元,跌22.22%;國茂控股(8428)收報0.5元,跌20.63%;錦藝集團控股(0565)收報1.02元,跌20.31%;迪諾斯環保(1452)收報0.064元,跌20%;時時服務(8181)收報0.08元,跌17.53%;世紀陽光(0509)收報0.275元,跌16.67%;德信服務(2215)創上市新低,見0.81元,收報0.81元,跌16.49%;奇士達(6918)創上市新低,見0.113元,收報0.121元,跌15.97%。 其他報道 渣打推出網上結構性產品平台 上證半日跌0.15% 深成升0.19% 港元拆息普遍向下 1個月HIBOR連跌4日 3個月息見3個月低 HKVAX伙勝利證券推進RWA和代幣化領域發展 強積金去年人均賺2.15萬元 錄8.82%回報創4年高 高盛:在岸人民幣或迅速貶值 以應對美國關稅措施衝擊 龍光:與若干境外債權人就境外債整體重組條款達成一致 高盛削亞股目標 增持中國 減持香港 人行據報將在港新發離岸人幣央票 規模遠超過去單次最大發行規模 優必選曾反彈12%

財新12月服務業PMI升至52.2 創7個月高 新出口訂單近兩年低 (10:01) – 20250106 – 即時財經新聞

財新智庫高級經濟學家王喆表示,2024年12月,製造業和服務業生產增加,需求增速近四個月來首次快於供給。但製造業及服務業就業均下降,物價水準整體較低迷,市場樂觀預期同樣趨弱。自9月底以來的系列存量政策和增量政策組合效應持續釋放,積極變化增多,國民經濟運作總體平穩,全年經濟社會發展主要目標可望順利實現。但同時,12月財新中國製造業PMI部分分項指數趨弱,前期政策刺激效果的持續性與有效性仍需進一步觀察。 2025年,外部環境將更加錯綜複雜,政策層面應事先準備及時回應。此外,後續政策還需向增加居民收入和改善民生傾斜,尤其要在提高弱勢群體消費能力和意願上多做文章。 報告內文: 先前公布的2024年12月財新中國製造業PMI下降1.0個百分點至50.5,仍位於擴張區間但擴張速度放緩。主要受製造業擴張速度放緩的拖累,當月財新中國綜合PMI回落0.9個百分點至51.4。 國家統計局近期公布的數據顯示,2024年12月製造業PMI下行0.2個百分點至50.1,服務業PMI則大幅上升1.9個百分點至52.0;服務業景氣上升的帶動大於製造業擴張放緩的拖累,綜合PMI產出指數走高1.4個百分點至52.2。 從財新中國服務業PMI分項數據看,2024年12月供需擴張速度微升,其中新訂單指數為近五個月來最高。但需求增加主要靠內需拉動,外需則陷入收縮狀態,新出口訂單指數為2023年8月來首次跌至臨界點以下,且為近兩年低點。樣本企業反映,海外客戶對中國服務業的興趣減弱。 儘管供需持續擴張,服務業就業情况卻出現惡化,12月就業指數為近四個月來首次降至收縮區間。受訪企業反映,員工離職和企業裁員共同導致用工數量下降。新訂單持續湧入,但企業人手萎縮,導致當月積壓工作量增加,相應指數在擴張區間升至下半年以來最高。 隨著原料價格及用工成本增加,12月投入品價格指數從上月僅略高於榮枯線位置小幅上升,但仍為年內較低水準。企業選擇提升售價以消化成本負擔,當月銷售物價指數升至擴張區間。 服務業企業對市場前景仍樂觀預期,但信心明顯走弱。 12月經營預期指數在擴張區間高點回落,降至歷史較低位置。一些企業認為,新業務品類推出,業務拓展力道加大,疊加政策扶持,有助於2025年推動銷售增長。但也有部分企業對競爭加劇和國際貿易前景感到擔憂。 其他報道 在岸人民幣貶值 續見逾一年最弱 內地金融時報「央行明確釋放穩匯率信號」 A股三大指數獨創板指高開 人行今淨回籠750億人幣 恒指高開88點 科指升0.67% 續低於10天線 申洲、京東升2% 12月本港PMI降至51.1 第四季增長較前數季好轉 今年開局或延續放緩趨勢 港股ADR升84點 夜期高水67點 美期跌亞股個別發展 泛遠國際63萬美元購美國清關服務供應商30%權益 易生活控股:召開罷免董事大會之人 已非公司股東 續停牌 北水增持工行 減持協鑫科技   Source link

港元拆息普遍向下 1個月HIBOR連跌4日 3個月息見3個月低 (11:17) – 20250106 – 即時財經新聞

港元現報7.7739元升值47點子,曾貶值最多15點子,報7.7801元,亦曾升值最多50點子,報7.7736元。 金管局貨幣基礎數據顯示,上日收市總結餘為448.72億元,與上日相同。 港元拆息、港元存息(彭博纽约综合利率)可看附圖。彭博終端機於6月1日起停止提供港元隔夜平均指數(HONIA)數據。 短線拆息方面,隔夜HIBOR跌2.36點子至4%,是2024年12月17日後最低;1星期HIBOR跌5.83點子至3.99571%,是2024年12月9日後最低;2星期HIBOR跌5.48點子至3.99571%,是2024年12月9日後最低。 中長線拆息方面,3個月期HIBOR跌3.46點子至4.12655%,是2024年9月26日後最低;6個月期HIBOR跌1.85點子至4.12845%,是2024年12月6日後最低;12個月期HIBOR升0.29點子至4.1431%,是1月2日後最高。 美元指數現報108.845貶值0.107點或0.1%。 按T+2顯示的最新美元1個月期LIBOR報4.96018%,將同一日的港元1個月期HIBOR減美元1個月期LIBOR的利差為-0.8102%,連續2日擴闊,利差是2024年11月25日後最闊,當日差距為-0.8294%。 對上一次連續2日擴闊,是2024年12月06日,當日利差報-0.6498%。 其他報道 HKVAX伙勝利證券推進RWA和代幣化領域發展 強積金去年人均賺2.15萬元 錄8.82%回報創4年高 高盛:在岸人民幣或迅速貶值 以應對美國關稅措施衝擊 龍光:與若干境外債權人就境外債整體重組條款達成一致 高盛削亞股目標 增持中國 減持香港 人行據報將在港新發離岸人幣央票 規模遠超過去單次最大發行規模 優必選曾反彈12% 再有董事承諾一年禁售持股 財新12月服務業PMI升至52.2 創7個月高 新出口訂單近兩年低 在岸人民幣貶值 續見逾一年最弱 內地金融時報「央行明確釋放穩匯率信號」 A股三大指數獨創板指高開 人行今淨回籠750億人幣 恒指高開88點 科指升0.67% 續低於10天線 申洲、京東升2% 12月本港PMI降至51.1 第四季增長較前數季好轉 今年開局或延續放緩趨勢 港股ADR升84點 夜期高水67點 美期跌亞股個別發展 泛遠國際63萬美元購美國清關服務供應商30%權益 易生活控股:召開罷免董事大會之人 已非公司股東 續停牌 北水增持工行 減持協鑫科技 Source link

恒指高開88點 科指升0.67% 續低於10天線 申洲、京東升2% (09:26) – 20250106 – 即時財經新聞

藍籌49隻升,11隻下跌,23隻無升跌。申洲國際(2313)升2.89%,報64元,是升幅最大的藍籌,小米(1810)跌0.97%,報35.9元,是跌幅最大的藍籌。 恒生科技指數成份股21隻升,4隻下跌,5隻無升跌。升幅最大的是京東(9618)開市報137.5元,升2.46%;跌幅最大的是嗶哩嗶哩(9626)開市報133.1元,跌0.97%。 恒指續於10天線(19887.88點)。科指續低於10天線(4454.97點)。 優必選(9880):再有股東自願承諾1年內不減持股份。開市報49.35元,升6.59%。 吉利汽車(0175)據報年內將推出「超醇電混」新車。開市報14.38元,升1.41%。 萬科企業(2202)去年銷售額大減1301億人幣。開市報5.15元,升1.18%。 盈健醫療(1419)以3885萬元收購祐德牙醫診所75%股權。開市報0.8元,升1.27%。 聯華超市(0980)1億人幣租上海物業開超市。無成交,報0.365元。 萬物雲(2602)斥2.3億人幣全購購物業管理商中洲物業。開市報20.05元,升0.35%。 非凡領越(0933)私有化堡獅龍今發股東通函,獨立財顧認為公平合理籲支持。無成交,報0.57元。 卓越教育(3978)未來3年派息比率擬由50%升至70%。開市報4元,升6.38%。 澳門郵電局:數碼通(0315)澳門客戶已全過渡至澳門電訊。無成交,報4.11元。 廣汽集團(2238)上月銷量升9%,去年銷量200萬輛跌20%。開市報3.16元,升0.32%。 信利國際(0732)終止分拆業務到內地上市。無成交,報1.14元。 鄭家純增持周大福珠寶(1929)10萬股,新世界股價今年首跌破5元大關。開市報6.69元,升1.21%。 世茂服務(0875)8316萬人幣購世路源環境33%股權,成全資附屬。無成交,報1.4元。 平安資管增持工行(1398)。開市報4.92元,升0.61%。 包浩斯(0483)首3財季同店銷售按年增長2%,上季增長10%。無成交,報0.235元。 破底股方面 創上市新低,包括九源基因(2566)低見6元,開市報6元,跌3.54%。 異動股 上升異動股,包括,華鼎控股(3398)開市報0.19元,升12.43%;融科控股(2323)開市報0.022元,升10%;皇璽餐飲集團(8300)開市報0.105元,升9.38%;中食民安(8283)開市報0.047元,升9.3%;思派健康(0314)開市報5.5元,升8.48%;紅星美凱龍(1528)開市報1.88元,升7.43%;新火科技控股(1611)開市報2.1元,升7.14%;優必選(9880)開市報49.35元,升6.59%;弘浩國際控股(8375)開市報6.82元,升6.4%;卓越教育集團(3978)開市報4元,升6.38%。 下跌異動股,包括,朗詩(0106)平上市低位0.011元,開市報0.011元,跌8.33%;中國鑄晨81(0810)開市報0.2元,跌6.98%;嬴集團(0397)開市報0.086元,跌6.52%;太美醫療科技(2576)開市報4元,跌5.88%;麗新發展(0488)開市報0.66元,跌5.71%;FI二南方納指(7568)開市報4.85元,跌4.34%;奧園(3883)開市報0.2元,跌4.31%;和鉑醫藥-B(2142)開市報2元,跌3.85%;九源基因(2566)創上市新低,見6元,開市報6元,跌3.54%。 其他報道 12月本港PMI降至51.1 第四季增長較前數季好轉 今年開局或延續放緩趨勢 港股ADR升84點 夜期高水67點 美期跌亞股個別發展 泛遠國際63萬美元購美國清關服務供應商30%權益 易生活控股:召開罷免董事大會之人 已非公司股東 續停牌 北水增持工行 減持協鑫科技 Source link

12月本港PMI降至51.1 第四季增長較前數季好轉 今年開局或延續放緩趨勢 (09:00) – 20250106 – 即時財經新聞

標普全球市場財智經濟研究部副總監JingyiPan表示,「最新標普全球香港特區採購經理指數反映,2024年底保持增長勢頭。產出指數第四季平均值創2023年第二季以後最高,反映經濟增長較之前數季好轉,惟12月增長步伐減慢,而前瞻指數也顯示,2025開局很可能延續放緩趨勢。外部需求減弱,壓抑着2024最後一月增長的銳氣,不少業者就美國關稅對貿易前景的潛在挑戰表示憂慮,有關影響還將在新的一年,繼續左右營商情緒和經濟狀況。企業為保銷路,不但承受成本升幅,還開始調低售價,意味業者面對的利潤壓力正在加重。綜觀不同行業數據,12月以批發及零售業最受影響」。 報告內容: 香港特區12月營商環境持續好轉,惟改善幅度較上月減慢。來自海外和中國內地的新增訂單量同時縮減,整體訂單增長因此放緩,連帶經營活動的擴張速度也進一步下滑。另一方面,企業對經營前景維持悲觀,繼而縮減員工規模,但仍繼續積極採購,並提高庫存水平。此外,業者於價格定位方面顯得謹慎,即使成本持續上漲,卻依然調低產出價格,有關跌幅更是2021年3月以來最大。 綜觀12月數據,則產出、新訂單、就業、採購庫存等分項指數均低於上月,導致PMI數值按月下跌。 企業從海外與中國內地新接的業務量温和減少,整體訂單增長隨之放緩至3個月最低。調查資料透露,外部需求疲軟,加上潛在的美國關稅威脅造成憂慮,因此拖累12月的出口訂單表現。 不過,本土客戶的採購意願增強,而且消費族群擴大,這兩項因素為新訂單提供了有力支撐,惠及企業連續3個月擴充營運,惟有關升幅不大。總的來說,12月以批發及零售業的商業活動增長最為突出。 企業在12月繼續看淡業務前景,但悲觀情緒較上月減退,業者的憂慮主要來自競爭加劇與貿易壁壘挑戰對後續銷情的影響。既然並不看好銷售前景,企業於是在年內第七度精簡人手,職位減幅雖然輕微,但與上月增聘員工的景況差別,也是3個月以來的最大跌幅。此外,積壓工作水平已連續兩月增加,反映產能壓力即使微升,卻沒有改變就業減少的出現。 為應付商業活動增長,企業繼續於12月積極採購,增幅與上月持平。由於有需要回補庫存,業者因此再度儲備投入品,有關增幅雖較上月放緩,但供應商延誤供貨,對採購庫存的擴張速度多少打了折扣;而事實反映,供應商表現的倒退程度創兩年半最差,調查資料也透露,投入品需求飈升,加上天氣干擾,造成供應商拖延付貨。 至於整體投入成本,則在12月繼續上升,但漲幅已回落至接近4年最低。綜合而言,員工成本在連升32月後回穩,但採購價格升幅卻是15個月最大,高於長期平均值;在原材料價格向上的情况下,採購成本持續加重,成為了推動整體投入成本的主力。雖然如此,企業並未將額外成本轉嫁客戶,反而為保銷路,調低銷售價格,屬7個月以來首次。 其他報道 港股ADR升84點 夜期高水67點 美期跌亞股個別發展 泛遠國際63萬美元購美國清關服務供應商30%權益 易生活控股:召開罷免董事大會之人 已非公司股東 續停牌 北水增持工行 減持協鑫科技 Source link

Take Warren Buffett’s Advice: Don’t Buy Any Stock in 2025 Unless It Passes This Test

Arguably the world’s greatest stock picker isn’t picking many stocks these days. Warren Buffett has been a net seller of stocks for eight consecutive quarters. I suspect when Berkshire Hathaway discloses the transactions it made in the fourth quarter of 2024, that count will increase to nine. There’s a reason Buffett isn’t buying many stocks

US set for IPO comeback as private equity firms seek to offload holdings

Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Wall Street bankers are gearing up for a revival in initial public offerings as private equity groups seek to tap buoyant US equities markets to offload some of their flagship holdings. Several private equity-backed groups

1 Stock to Buy, 1 Stock to Sell This Week: AMD, Constellation Brands

• U.S. jobs report, Fed FOMC Meeting minutes will be in focus this week. • AMD is a buy as it gets ready to showcase its next-gen GPU at CES 2025. • Constellation Brands is a sell with downbeat earnings, disappointing guidance on deck. • Looking for more actionable trade ideas? Subscribe here for 50%

Wish You’d Bought Palantir in 2024? Buy This Unstoppable ETF Instead

Palantir was the top-performing AI stock in 2024, but can its gains continue this year? It’s official: 2024 is in the books and all eyes are on what this year will bring. As expected, artificial intelligence (AI) stocks continued to pave the way for market-beating returns last year. While the “Magnificent Seven” held their own,

0
Would love your thoughts, please comment.x
()
x